Highlights bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
1.88 ^USD	+0.53%		-9.18%	+27.85%

15/05	Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M	MT
01/04	BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M	15/05	MT
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q3 Revenue $298,484	15/11	MT
BioAffinity Technologies, Inc. Provides Earnings Guidance for the Year 2023 and for the Next 12 Months(fourth quarter 2023 to third quarter 2024)	15/11	CI
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
BioAffinity Technologies Unit Acquires Precision Pathology Services Laboratory Assets; Shares Rise	19/23/19	MT
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Reports Q2 Revenue $19,738	15/23/15	MT
BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
AMA Issues CPT Code for bioAffinity Technologiesâ€™ CyPathÂ® Lung Test for Early-Stage Lung Cancer	12/23/12	CI
BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $921	15/23/15	MT
BioAffinity Technologies to Ring Nasdaq Closing Bell Today	05/23/05	BU
BioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results	01/23/01	BU
BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	01/23/01	AQ
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
BioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath Lung for Noninvasive Detection of Early-Stage Lung Cancer	28/23/28	CI
BioAffinity Technologies, Inc. Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research	24/23/24	CI
Bioaffinity Technologies Announces Notice to Award U.S. Patent and Trademark Office Protecting Novel Compounds for Specific Delivery of Cancer Treatments	04/23/04	CI
BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	15/22/15	AQ
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Highlights

Filters